Director/PDMR Shareholding

RNS Number : 8660Q
Spectra Systems Corporation
22 February 2019
 

Spectra Systems Corporation

("Spectra Systems" or the "Company")

Director Dealings

Spectra Systems announces that on 21 February 2019, Martin Jaskel, Non-executive Director of the Company, sold 28,003 shares of common stock of $0.01 in the Company. 

Enquiries:

Spectra Systems Corporation

   Dr. Nabil Lawandy, Chief Executive Officer                                            Tel: +1 (0) 401 274 4700

WH Ireland Limited

   Chris Fielding (Managing Director, Corporate Finance)                           Tel: +44 (0) 20 7220 1650

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Martin Jaskel

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectra Systems Corporation

b)

LEI

21380047EWJYQG53D640

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Common stock of US$0.01

 

 

ISIN: US84756T1060

TIDM: SPSY

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

130.25

18,003

130.35

10,000

d)

Aggregated information

-     Aggregated volume

-     Price

 

28,003

130.29

e)

Date of the transaction

21 February 2019

f)

Place of the transaction

London Stock Exchange

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUURKRKAAUURR
UK 100

Latest directors dealings